Compare $VERA vs $ZBIO | Chartloom

Compare

$VERA vs $ZBIO

Vera Therapeutics, Inc · Zenas Biopharma Inc

VERA

Vera Therapeutics, Inc

ZBIO

Zenas Biopharma Inc

Compare $VERA vs $ZBIO

Comparing Vera Therapeutics, Inc and Zenas Biopharma Inc

VERAVera Therapeutics, Inc

ZBIOZenas Biopharma Inc

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

ZBIOZenas Biopharma Inc

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-93.3%

YTD performance

-21.0%

52W performance

5.3%

FCF yield

-16.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VERA

ZBIO

Detailed metrics comparison

VERA

Vera Therapeutics, Inc

ZBIO

Zenas Biopharma Inc

Market Cap

VERA$2.14B

ZBIO$1.72B

Enterprise Value

VERA$2.17B

ZBIO$1.91B

Price

VERA$29.88

ZBIO$27.26

P/E Ratio

VERAN/A

ZBION/A

P/S Ratio

VERA0.00x

ZBIO1,720.92x

EV/Sales

VERA0.00x

ZBIO1,913.10x

EV/EBITDA

VERA0.00x

ZBIO0.00x

P/B Ratio

VERA5.38x

ZBIO7.47x

P/FCF Ratio

VERAN/A

ZBION/A

EV/FCF

VERA-6.40x

ZBIO-6.57x

PEG Ratio

VERAN/A

ZBION/A

Forward P/E (NTM)

VERAN/A

ZBION/A

Forward P/S (NTM)

VERA19.87x

ZBION/A

Revenue (TTM)

VERA$0

ZBIO$1M

Revenue Growth (YoY)

VERAN/A

ZBIO-93.3%

Forward Rev Growth

VERA698.6%

ZBIO5296.9%

Gross Margin (TTM)

VERA0.0%

ZBIO0.0%

Operating Margin (TTM)

VERA0.0%

ZBIO0.0%

EBITDA Margin (TTM)

VERA0.0%

ZBIO-27387.0%

Net Margin (TTM)

VERA0.0%

ZBIO-48438.4%

FCF Margin (TTM)

VERAN/A

ZBIO-29097.4%

Net Income (TTM)

VERA$-402M

ZBIO$-484M

FCF (TTM)

VERA$-339M

ZBIO$-291M

EPS (TTM)

VERA-$5.59

ZBIO-$7.67

ROE (TTM)

VERA-8413.0%

ZBIO-18968.0%

ROA (TTM)

VERA-6679.0%

ZBIO-8991.0%

ROIC (TTM)

VERA-7272.0%

ZBIO-10131.0%

Cash

VERA$49M

ZBIO$197M

Debt

VERA$75M

ZBIO$389M

Net Cash/Debt

VERA$-26M

ZBIO$-192M

Current Ratio (TTM)

VERA10.92x

ZBIO9.93x

Quick Ratio (TTM)

VERA10.50x

ZBIO9.77x

Debt/Equity (TTM)

VERA0.18x

ZBIO1.57x

Debt/Assets (TTM)

VERA0.0%

ZBIO0.0%

Interest Coverage (TTM)

VERAN/A

ZBION/A

Net Debt/EBITDA (TTM)

VERA0.00x

ZBIO0.00x

Beta

VERA1.13

ZBIO0.70

52W Performance

VERA-2.0%

ZBIO5.3%

YTD Performance

VERA-38.5%

ZBIO-21.0%

% from 52W High

VERA-46.7%

ZBIO-38.9%

% from 52W Low

VERA29.6%

ZBIO101.9%

Asset Turnover (TTM)

VERA0.00x

ZBIO0.00x

FCF Yield (TTM)

VERA-15.8%

ZBIO-16.9%

Earnings Yield (TTM)

VERA-18.7%

ZBIO-28.1%

Dividend Yield (TTM)

VERAN/A

ZBION/A

Rule of 40

VERA0.0

ZBIO-29,190.7

EV/GP/RG

VERAN/A

ZBION/A

Ticker research

View VERA research View ZBIO research

Metric	VERA Vera Therapeutics, Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$2.14B	$1.72B
Enterprise Value	$2.17B	$1.91B
Price	$29.88	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,720.92x
EV/Sales	0.00x	1,913.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.38x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.40x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.87x	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-93.3%
Forward Rev Growth	698.6%	5296.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-27387.0%
Net Margin (TTM)	0.0%	-48438.4%
FCF Margin (TTM)	N/A	-29097.4%
Net Income (TTM)	$-402M	$-484M
FCF (TTM)	$-339M	$-291M
EPS (TTM)	-$5.59	-$7.67
ROE (TTM)	-8413.0%	-18968.0%
ROA (TTM)	-6679.0%	-8991.0%
ROIC (TTM)	-7272.0%	-10131.0%
Financial Health
Cash	$49M	$197M
Debt	$75M	$389M
Net Cash/Debt	$-26M	$-192M
Current Ratio (TTM)	10.92x	9.93x
Quick Ratio (TTM)	10.50x	9.77x
Debt/Equity (TTM)	0.18x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	0.70
52W Performance	-2.0%	5.3%
YTD Performance	-38.5%	-21.0%
% from 52W High	-46.7%	-38.9%
% from 52W Low	29.6%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.8%	-16.9%
Earnings Yield (TTM)	-18.7%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-29,190.7
EV/GP/RG	N/A	N/A
Ticker research	View VERA research	View ZBIO research

Valuation

P/S Ratio

VERA

0.00x

ZBIO

1,720.92x

EV/FCF

ZBIO

-6.57x

VERA

-6.40x

Growth & revenue

Revenue Growth TTM

ZBIO

-93.3%

Forward Revenue Growth

ZBIO

5296.9%

VERA

698.6%

Profitability & performance

Gross Margin

VERA

0.0%

ZBIO

0.0%

ROE

VERA

-8413.0%

ZBIO

-18968.0%

FCF Yield %

VERA

-15.8%

ZBIO

-16.9%

52-Week Performance

ZBIO

5.3%

VERA

-2.0%

Detailed metrics comparison

VERA

Vera Therapeutics, Inc

ZBIO

Zenas Biopharma Inc

Market Cap

VERA$2.14B

ZBIO$1.72B

Enterprise Value

VERA$2.17B

ZBIO$1.91B

Price

VERA$29.88

ZBIO$27.26

P/E Ratio

VERAN/A

ZBION/A

P/S Ratio

VERA0.00x

ZBIO1,720.92x

EV/Sales

VERA0.00x

ZBIO1,913.10x

EV/EBITDA

VERA0.00x

ZBIO0.00x

P/B Ratio

VERA5.38x

ZBIO7.47x

P/FCF Ratio

VERAN/A

ZBION/A

EV/FCF

VERA-6.40x

ZBIO-6.57x

PEG Ratio

VERAN/A

ZBION/A

Forward P/E (NTM)

VERAN/A

ZBION/A

Forward P/S (NTM)

VERA19.87x

ZBION/A

Revenue (TTM)

VERA$0

ZBIO$1M

Revenue Growth (YoY)

VERAN/A

ZBIO-93.3%

Forward Rev Growth

VERA698.6%

ZBIO5296.9%

Gross Margin (TTM)

VERA0.0%

ZBIO0.0%

Operating Margin (TTM)

VERA0.0%

ZBIO0.0%

EBITDA Margin (TTM)

VERA0.0%

ZBIO-27387.0%

Net Margin (TTM)

VERA0.0%

ZBIO-48438.4%

FCF Margin (TTM)

VERAN/A

ZBIO-29097.4%

Net Income (TTM)

VERA$-402M

ZBIO$-484M

FCF (TTM)

VERA$-339M

ZBIO$-291M

EPS (TTM)

VERA-$5.59

ZBIO-$7.67

ROE (TTM)

VERA-8413.0%

ZBIO-18968.0%

ROA (TTM)

VERA-6679.0%

ZBIO-8991.0%

ROIC (TTM)

VERA-7272.0%

ZBIO-10131.0%

Cash

VERA$49M

ZBIO$197M

Debt

VERA$75M

ZBIO$389M

Net Cash/Debt

VERA$-26M

ZBIO$-192M

Current Ratio (TTM)

VERA10.92x

ZBIO9.93x

Quick Ratio (TTM)

VERA10.50x

ZBIO9.77x

Debt/Equity (TTM)

VERA0.18x

ZBIO1.57x

Debt/Assets (TTM)

VERA0.0%

ZBIO0.0%

Interest Coverage (TTM)

VERAN/A

ZBION/A

Net Debt/EBITDA (TTM)

VERA0.00x

ZBIO0.00x

Beta

VERA1.13

ZBIO0.70

52W Performance

VERA-2.0%

ZBIO5.3%

YTD Performance

VERA-38.5%

ZBIO-21.0%

% from 52W High

VERA-46.7%

ZBIO-38.9%

% from 52W Low

VERA29.6%

ZBIO101.9%

Asset Turnover (TTM)

VERA0.00x

ZBIO0.00x

FCF Yield (TTM)

VERA-15.8%

ZBIO-16.9%

Earnings Yield (TTM)

VERA-18.7%

ZBIO-28.1%

Dividend Yield (TTM)

VERAN/A

ZBION/A

Rule of 40

VERA0.0

ZBIO-29,190.7

EV/GP/RG

VERAN/A

ZBION/A

Ticker research

View VERA research View ZBIO research

Metric	VERA Vera Therapeutics, Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$2.14B	$1.72B
Enterprise Value	$2.17B	$1.91B
Price	$29.88	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,720.92x
EV/Sales	0.00x	1,913.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.38x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.40x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	19.87x	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-93.3%
Forward Rev Growth	698.6%	5296.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-27387.0%
Net Margin (TTM)	0.0%	-48438.4%
FCF Margin (TTM)	N/A	-29097.4%
Net Income (TTM)	$-402M	$-484M
FCF (TTM)	$-339M	$-291M
EPS (TTM)	-$5.59	-$7.67
ROE (TTM)	-8413.0%	-18968.0%
ROA (TTM)	-6679.0%	-8991.0%
ROIC (TTM)	-7272.0%	-10131.0%
Financial Health
Cash	$49M	$197M
Debt	$75M	$389M
Net Cash/Debt	$-26M	$-192M
Current Ratio (TTM)	10.92x	9.93x
Quick Ratio (TTM)	10.50x	9.77x
Debt/Equity (TTM)	0.18x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	0.70
52W Performance	-2.0%	5.3%
YTD Performance	-38.5%	-21.0%
% from 52W High	-46.7%	-38.9%
% from 52W Low	29.6%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.8%	-16.9%
Earnings Yield (TTM)	-18.7%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-29,190.7
EV/GP/RG	N/A	N/A
Ticker research	View VERA research	View ZBIO research